Peptide Handling & Safety

Tap water is not sterile and must not be used to prepare injectable medication. The appropriate preparation fluid must be specified by the product's official instructions or determined by a qualified pharmacist.

Sterile Water for Injection and bacteriostatic water are not automatically interchangeable. Their composition, intended use and suitability differ. Do not select a diluent based on advice for a different medication or peptide.

Sources: United States Pharmacopeia (USP), Sterile Water for Injection; CDC, Preventing Unsafe Injection Practices.

Injectable medicines require appropriate aseptic handling. Preparation should take place in a suitable clean area, away from potential contamination sources, and in accordance with product instructions and professional training.

• Use a new sterile needle and syringe for every injection and every vial entry.
• Never reuse a syringe, even if the needle is changed.
• Follow official instructions for disinfecting vial closures and allowing the disinfectant to dry.
• Do not use a product if its container is damaged or sterility may have been compromised.

Source: CDC, Preventing Unsafe Injection Practices.

There is no reliable universal rule that every peptide must never be shaken. A molecule's sensitivity to agitation, temperature, light and handling depends on its formulation and the available stability evidence.

Only follow a specific “do not shake,” mixing or handling instruction when it is supported by the relevant official product documentation or suitable stability research. Do not infer a rule for one peptide from another.

Evidence limitation: CDC injection-safety guidance addresses infection prevention. It does not establish peptide-specific stability or a universal no-shaking rule.

Storage requirements depend on the exact substance, formulation, packaging and whether the product has been opened or prepared. Do not assume every peptide needs refrigeration, that freezing extends its usable life, or that one storage temperature fits all products.

Use the relevant authorised product instructions or validated stability data for temperature limits, light protection and any time limit after opening or preparation. Do not use a product when its storage history or integrity is uncertain.

Sources: CDC, injection safety and vial handling; USP General Chapter <797>, Pharmaceutical Compounding—Sterile Preparations.

A single-dose vial is intended for one patient for one procedure or injection, as defined by its labelling and applicable guidance. Do not treat leftover contents as reusable merely because liquid remains, and do not pool leftovers from separate single-dose containers.

Use multidose containers only when they are clearly labelled for that purpose and follow their official instructions. A preservative does not eliminate the risk of contamination.

Source: CDC, Preventing Unsafe Injection Practices.

A clear solution, professional label or certificate of analysis (CoA) does not, by itself, prove that a product is sterile, free of endotoxins, accurately concentrated, free of impurities, or suitable for human use.

These are separate quality questions. A document is only as useful as its scope, methods, sample traceability, laboratory competence and ability to link the tested sample to the actual batch. A purity result alone is not proof of sterility.

“Research use only” labelling does not establish suitability for human use. Unapproved products may have unverified identity, quality, strength or safety.

Source: US Food and Drug Administration (FDA), Compounding and FDA: Questions and Answers.

Established principle
Supported by official public-health or pharmaceutical guidance, such as preventing reuse of injection equipment.

Product-specific evidence required
Cannot be safely generalised across peptides. Examples include diluent compatibility, refrigeration, light sensitivity and agitation limits.

Important limitation
A claim that cannot be established by the cited source, or a quality issue that requires separate verification. Forum posts and vendor claims should not be presented as established medical facts.